Gene therapy in ophthalmology

Present status of clofibrate therapy in ophthalmology.

The Interface between Ophthalmology Optometricvision Therapy

Considerable disparity lies between ophthalmologic impressions of optometric vision therapy, and the reality of optometric vision therapy as practiced in the United States. The viewpoint shared by ophthalmology in particular, and the medical field in general, is one that is filtered through organizational policy statements and the isolated experiences of influential individual practitioners. Th...

Recent Advances in Hemophilia Gene Therapy

Heterogeneous loss of function mutations at F8 and F9 genes causes X-linked recessive bleeding disorders, hemophilia A (HA) and hemophilia B (HB), respectively. HA is clinically indistinguishable from HB and accounts for more than 80% of hemophilia cases; the former affects 1/5000 and the latter 1/25000 male births worldwide. In Iran, it is estimated that around 4300 HA and 900 HB patients are ...

Tuberculin in Ophthalmology Tuberculin in Ophthalmology

ژن درمانی Gene Therapy